Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM, Tindall DJ.

Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1649-54. Epub 2005 Jan 24.

PMID:
15668399
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis.

Pagano M.

Mol Cell. 2004 May 21;14(4):414-6. Review.

PMID:
15149588
[PubMed - indexed for MEDLINE]
Free Article
3.

Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.

Hershko DD.

Cancer. 2008 Apr 1;112(7):1415-24. doi: 10.1002/cncr.23317. Review.

PMID:
18260093
[PubMed - indexed for MEDLINE]
Free Article
4.

Regulation of FOXO protein stability via ubiquitination and proteasome degradation.

Huang H, Tindall DJ.

Biochim Biophys Acta. 2011 Nov;1813(11):1961-4. doi: 10.1016/j.bbamcr.2011.01.007. Epub 2011 Jan 14. Review.

PMID:
21238503
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

FOXO factors: a matter of life and death.

Huang H, Tindall DJ.

Future Oncol. 2006 Feb;2(1):83-9. Review.

PMID:
16556075
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk